Progesterone receptor isoform ratio dictates antiprogestins/progestins effects on metastatic breast cancer models

被引:0
|
作者
Abascal, M. F. [1 ]
Giulianelli, S. [2 ]
Alvarez, M. [1 ]
Sequeira, G. [3 ]
Vanzulli, S. [4 ]
Elia, A. [1 ]
Pataccini, G. [1 ]
Lombes, M. [5 ,6 ]
Lanari, C. [1 ]
机构
[1] IBYME, Lab Carcinogenesis Hormonal, Buenos Aires, DF, Argentina
[2] CENPAT, CONICET, IBIOMAR, CCT, Puerto Madryn, Argentina
[3] Hosp Autogest Dr Arturo Onativia, Lab Biol Mol, Salta, Argentina
[4] Acad Med, Dept Patol, Caba, Argentina
[5] INSERM, U1185, Paris, France
[6] Univ Paris Saclay, Fac Med Paris Sud, UMS 32, Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
259P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] The ratio of progesterone receptor isoform A to B determines the effect of antiprogestins on preclinical models of breast cancer metastasis
    Lanari, C.
    Alvarez, M.
    Giulianelli, S.
    Marina, R.
    Sequeira, G.
    May, M.
    Novaro, V.
    Sahores, A.
    Lamb, C.
    CANCER RESEARCH, 2016, 76
  • [2] THE PROGESTERONE-RECEPTOR - BIOLOGICAL EFFECTS OF PROGESTINS AND ANTIPROGESTINS
    SAVOURET, JF
    CHAUCHEREAU, A
    MISRAHI, M
    LESCOP, P
    MANTEL, A
    BAILLY, A
    MILGROM, E
    HUMAN REPRODUCTION, 1994, 9 : 7 - 11
  • [3] THE EFFECTS OF PROGESTINS ANTIPROGESTINS ON PROLIFERATION AND PROGESTERONE-RECEPTOR EXPRESSION IN HUMAN BREAST-CANCER CELLS
    VANDENBERG, HW
    MARTIN, J
    LYNCH, M
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 531 - 531
  • [4] Progesterone receptor isoform ratio dictates antiprogestin/progestin effects on breast cancer growth and metastases: A role for NDRG1
    Florencia Abascal, Maria
    Elia, Andres
    Alvarez, Michelle
    Pataccini, Gabriela
    Sequeira, Gonzalo
    Riggio, Marina
    Figueroa, Virginia
    Lamb, Caroline A.
    Rojas, Paola A.
    Spengler, Eunice
    Martinez-Vazquez, Paula
    Burruchaga, Javier
    Liguori, Marcos
    Sahores, Ana
    Wargon, Victoria
    Molinolo, Alfredo
    Hewitt, Stephen
    Lombes, Marc
    Sartorius, Carol
    Ines Vanzulli, Silvia
    Giulianelli, Sebastian
    Lanari, Claudia
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (09) : 1481 - 1496
  • [5] The role of progestins and antiprogestins in the treatment of breast cancer
    Bonney, RC
    ENDOCRINE-RELATED CANCER, 1996, 3 (02) : 113 - 125
  • [6] Antiprogestins as Possible Therapeutic Agents for Breast Cancer Patients Showing a High Expression of the Progesterone Receptor Isoform A
    Rojas, P. A.
    Sequeira, G.
    Gonzalez, P.
    Bagnati, A.
    Urrutia, A.
    Medel, J.
    Vazquez, P. Martinez
    Gass, H.
    Lanari, C.
    CANCER RESEARCH, 2010, 70
  • [7] The effects of progesterone receptor isoforms are differentially regulated by putative antiprogestins in breast cancer cells
    Lin, Valerie C.
    Leo, Joyce Cl
    CANCER RESEARCH, 2006, 66 (08)
  • [8] CHARACTERIZATION AND PHOSPHORYLATION OF PROGESTERONE-RECEPTOR FROM T47D HUMAN BREAST-CANCER CELLS BY PROGESTINS AND ANTIPROGESTINS
    IWASAKI, K
    KODALI, S
    UNDERWOOD, B
    HERMAN, M
    DINDA, S
    MOUDGIL, VK
    FASEB JOURNAL, 1994, 8 (07): : A1316 - A1316
  • [9] Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness
    Rojas, Paola A.
    May, Maria
    Sequeira, Gonzalo R.
    Elia, Andres
    Alvarez, Michelle
    Martinez, Paula
    Gonzalez, Pedro
    Hewitt, Stephen
    He, Xiaping
    Perou, Charles M.
    Molinolo, Alfredo
    Gibbons, Luz
    Abba, Martin C.
    Gass, Hugo
    Lanari, Claudia
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (07):
  • [10] Progesterone receptor isoform ratios influence the transcriptional activity of progestins via the progesterone receptor
    Cartwright, Meghan
    Louw-du Toit, Renate
    Jackson, Hayley
    van Vuuren, Melani Janse
    Africander, Donita
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2023, 232